Van Lanschot Kempen Investment Management N.V.
Source: SEC Form 13F · as of Mar 2026Van Lanschot Kempen Investment Management N.V. holds 14 biotech & pharma companies tracked by BioSniper, totaling $495.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$495.4M
| Company | Shares | Value |
|---|---|---|
| ZTSZoetis Inc. | 1,050,678 | $124.2M |
| ICLRICON plc | 918,713 | $101.7M |
| MRKMerck & Co., Inc. | 522,959 | $62.9M |
| DGXQuest Diagnostics Incorporated | 256,298 | $50.2M |
| LLYELI LILLY & Co | 45,972 | $42.3M |
| GILDGILEAD SCIENCES, INC. | 267,255 | $37.2M |
| ABTABBOTT LABORATORIES | 174,852 | $18.0M |
| QGENQIAGEN N.V. | 431,253 | $17.3M |
| ABBVAbbVie Inc. | 68,976 | $15.0M |
| WSTWest Pharmaceutical Services Inc. | 51,501 | $12.9M |
| IQVIQVIA Holdings Inc. | 44,839 | $7.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 21,635 | $5.9M |
| MCKMcKesson Corporation | 200 | $173K |
| ELVElevance Health Inc. | 414 | $121K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.